Sean “Diddy” Combs would have a hard time launching a comeback despite his acquittal on the most severe charges because of ...

Merck Mercuriadis, founder of the influential catalog investment group Hipgnosis, is preparing to launch a re-vamped version ...

Merck Mercuriadis aims to buy back the music rights he sold to the private equity firm while building a new investment ...

Merck Mercuriadis, the architect behind Hipgnosis’s transformation of music rights into a mainstream asset class, is making a ...

Merck is a massive company with strong fundamentals and underlying value at a heavily discounted price. Click here to find ...

Merck & Co., Inc. (NYSE: MRK) is one of the. The company announced that the US FDA approved ENFLONSIA™ (clesrovimab-cfor) for ...

RAHWAY, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced positive topline results from the first two of three Phase 3 clinical trials ...

Explore the Hipgnosis founder's new venture, focused on music management and co-ownership for artists and managers.

On Thursday, RFK’s Advisory Committee on Immunization Practices (ACIP) voted to recommend clesrovimab, a new RSV antibody shot made by Merck, for infants 8 months and younger who don’t have ...

Business Wire India • Link to Live Stream of Inaugural Session of Merck Foundation First Ladies Initiative – MFFLI Summit 2025: Merck Foundation, the philanthropic arm of Merck KGaA Germany, ...

I've written this kind of article before, addressing whether it's smart to buy into the dividend-paying stocks in the S&P 500 ...

U.S. Health Secretary Robert F. Kennedy Jr.'s newly revamped vaccine advisory panel voted on Thursday for recommending use of ...